title: Emergence of catalytic bioscavengers against organophosphorus agents.
abstract: Bioscavengers are an effective alternative approach for pre- and post-exposure treatments of nerve agent (NA) poisoning. Bioscavengers are natural or recombinant enzymes, reactive proteins, and antibodies that neutralize NAs before they reach their physiological targets. They are administered by injection (protein or gene delivery vector) and react with NAs in the bloodstream. Other ways of delivery can be used: inhalation for pulmonary delivery, topical creams for skin protection, etc. Operational bioscavengers must be producible at low cost, not susceptible to induce immune response and adverse effects, and stable in the bloodstream, upon storage, and under field conditions. First generation bioscavengers, cholinesterases and carboxylesterases, are stoichiometric bioscavengers. However, stoichiometric neutralization of NAs needs administration of huge doses of costly biopharmaceuticals. Second generation bioscavengers are catalytic bioscavengers. These are capable of detoxifying organophosphates regeneratively. By virtue of high turnover, much lower doses are needed for rapid neutralization of toxicants. The most promising catalytic bioscavengers are evolved mutants of phosphotriesterases (bacterial enzymes, mammalian paraoxonases), displaying enantiomeric preference for toxic NA isomers. However, engineering of cholinesterases, carboxylesterases, prolidases and other enzymes, e.g. phosphotriesterases-lactonases from extremophiles is of interest. In particular, association of cholinesterase mutants (not susceptible to age after phosphylation) with fast-reactivating oximes leads to pseudocatalytic bioscavengers. Thus, catalytic and pseudocatalytic bioscavengers are an improvement of bioscavenger-based medical countermeasures in terms of efficacy and cost.
authors.affiliation: Neuropharmacology Laboratory, Kazan Federal University, 18 Kremlevskaia St., 48000 Kazan, Russian Federation. Electronic address: pym.masson@free.fr.
authors.forename: Patrick
authors.initials: P
authors.lastname: Masson
authors.affiliation: Emanuel Institute of Biophysical Physics of Russian Academy of Sciences, Moscow, Russian Federation.
authors.forename: Sofya V
authors.initials: SV
authors.lastname: Lushchekina
mesh_terms: D000818:Animals; D055162:Biocatalysis / Q000187:drug effects*; D006801:Humans; D008954:Models, Biological; D000066829:Neuroprotection / Q000187:drug effects; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009943:Organophosphorus Compounds / Q000633:toxicity*
chemical_list: D018696:Neuroprotective Agents; D009943:Organophosphorus Compounds
keywords: Biopharmaceutical; Bioscavenger; Cholinesterase; Nerve agent; Organophosphorus compound; Paraoxonase; Phosphotriesterase